Metraipolis › archive › dc_bc60239bf30e

Human Epidermal Growth Factor Receptor 2 Negative, Low, and Overexpression in Breast Cancer Patients: Study on Recurrence-Free and Overall Survival — Europe PMC PMID:42490783

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42490783
DOI: 10.14740/wjon2780
License (as archived): solo-consultazione
Archived: 2026-10-18T19:51:30.410Z
SHA-256 of the archived text: 517c07edf576029e2ac72a2a20054de314dd5246cb0625688f5aa2498fbb262b
Stable URL of this page: https://metraipolis.com/documento/dc_bc60239bf30e

How to cite

Human Epidermal Growth Factor Receptor 2 Negative, Low, and Overexpression in Breast Cancer Patients: Study on Recurrence-Free and Overall Survival — Europe PMC PMID:42490783 — Europe PMC (en), https://europepmc.org/article/MED/42490783 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bc60239bf30e (Metraipolis archive dc_bc60239bf30e, sha256 517c07edf576029e2ac72a2a20054de314dd5246cb0625688f5aa2498fbb262b)

BibTeX

@misc{dcbc60239bf30e,
  title = {Human Epidermal Growth Factor Receptor 2 Negative, Low, and Overexpression in Breast Cancer Patients: Study on Recurrence-Free and Overall Survival — Europe PMC PMID:42490783},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42490783},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bc60239bf30e; sha256 517c07edf576029e2ac72a2a20054de314dd5246cb0625688f5aa2498fbb262b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42490783. Agents can read the archived copy with the MCP tool read_document.